Transcatheter Aortic Valve Replacement

Greater Treatment Options for AVS Patients with a Lower Surgical Risk of Major Complications

Last month, the U.S. Food and Drug Administration (FDA), an agency within the U.S. Department of Health and Human Services, that protects the public health, approved an expanded indication for several transcatheter heart valves to include patients with severe aortic valve stenosis (Sapien 3, Sapien 3 Ultra, CoreValve Evolut R and CoreValve Evolut PRO) at low surgical risk …

Greater Treatment Options for AVS Patients with a Lower Surgical Risk of Major Complications Read More »

Study Says Most Patients Can Now Benefit from TAVR Procedure

According to the Columbia Surgery blog, Transcatheter Aortic Valve Replacement (TAVR), is considered the new “gold-standard” for treating people suffering from aortic valve disease. In the TAVR procedure, considered less-invasive for fixing stiff, damaged aortic valves (called aortic stenosis) than traditional valve surgery, doctors get to the aortic valve through by using very small incisions …

Study Says Most Patients Can Now Benefit from TAVR Procedure Read More »